| Post |
| Pre |
| LA |
|---|
| - |
| - |
| ME 1 | ME 2 | ME 3 | ME 4 | ME 5 | ME 6 | ME 7 | ME 8 | ME 9 | ME 10 | Total |
|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 105 | 11 | 181 | 1,959 | 40 | - | - | - | 2,296 |
| - | - | - | - | 191 | 1,098 | 8 | - | - | - | 1,297 |
| Post |
| Pre |
| LO 1 | LO 2 | LO 3 | LO 4 | LO 5A | LO 5B | LO 6 | Total |
|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - |
| - | - | - | - | - | - | - | - |
| AME |
|---|
| 3 |
| 1 |
| Post |
| Pre |
| LOP 1 | LOP 2 | LOP 3 | LOP 4 | Total |
|---|---|---|---|---|
| - | - | - | - | - |
| - | - | - | - | - |
| central brain |
|---|
| - |
| - |

| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| ME(L) | 2,296 | 99.8% | -0.82 | 1,297 | 99.9% |
| AME(L) | 3 | 0.1% | -1.58 | 1 | 0.1% |
| Optic-unspecified(L) | 1 | 0.0% | -inf | 0 | 0.0% |
| upstream partner | # | NT | conns Cm32 | % In | CV |
|---|---|---|---|---|---|
| Cm1 (L) | 217 | ACh | 989 | 46.1% | 0.6 |
| Cm28 (L) | 6 | Glu | 235 | 11.0% | 0.3 |
| Cm2 (L) | 83 | ACh | 175 | 8.2% | 0.5 |
| Cm10 (L) | 24 | GABA | 68 | 3.2% | 0.8 |
| Dm3a (L) | 26 | Glu | 47 | 2.2% | 0.5 |
| Dm2 (L) | 34 | ACh | 42 | 2.0% | 0.4 |
| Tm5c (L) | 30 | Glu | 41 | 1.9% | 0.4 |
| Cm11a (L) | 18 | ACh | 38 | 1.8% | 0.7 |
| Cm31a (L) | 2 | GABA | 36 | 1.7% | 0.2 |
| OLVC2 (R) | 1 | GABA | 26 | 1.2% | 0.0 |
| Dm3b (L) | 14 | Glu | 24 | 1.1% | 0.5 |
| Cm22 (L) | 6 | GABA | 18 | 0.8% | 1.1 |
| Cm19 (L) | 9 | GABA | 15 | 0.7% | 0.5 |
| Tm29 (L) | 11 | Glu | 14 | 0.7% | 0.7 |
| Mi16 (L) | 11 | GABA | 14 | 0.7% | 0.5 |
| Dm20 (L) | 10 | Glu | 13 | 0.6% | 0.4 |
| Mi15 (L) | 11 | ACh | 12 | 0.6% | 0.3 |
| Cm29 (L) | 3 | GABA | 11 | 0.5% | 0.5 |
| L3 (L) | 5 | ACh | 11 | 0.5% | 0.5 |
| Cm9 (L) | 7 | Glu | 11 | 0.5% | 0.5 |
| MeVPMe7 (L) | 1 | Glu | 10 | 0.5% | 0.0 |
| Tm35 (L) | 5 | Glu | 10 | 0.5% | 0.8 |
| Cm26 (L) | 5 | Glu | 10 | 0.5% | 0.5 |
| Tm30 (L) | 7 | GABA | 10 | 0.5% | 0.5 |
| Cm5 (L) | 8 | GABA | 10 | 0.5% | 0.3 |
| Tm40 (L) | 9 | ACh | 10 | 0.5% | 0.3 |
| Tm31 (L) | 7 | GABA | 10 | 0.5% | 0.3 |
| Dm8a (L) | 6 | Glu | 9 | 0.4% | 0.3 |
| MeVPMe11 (R) | 1 | Glu | 8 | 0.4% | 0.0 |
| ME_unclear (L) | 2 | Glu | 8 | 0.4% | 0.8 |
| Mi10 (L) | 6 | ACh | 8 | 0.4% | 0.4 |
| Tm5a (L) | 6 | ACh | 8 | 0.4% | 0.4 |
| MeVPMe7 (R) | 1 | Glu | 7 | 0.3% | 0.0 |
| TmY17 (L) | 6 | ACh | 7 | 0.3% | 0.3 |
| Cm3 (L) | 6 | GABA | 7 | 0.3% | 0.3 |
| Tm6 (L) | 1 | ACh | 6 | 0.3% | 0.0 |
| MeVP6 (L) | 5 | Glu | 6 | 0.3% | 0.3 |
| MeVC22 (L) | 1 | Glu | 5 | 0.2% | 0.0 |
| aMe17e (L) | 1 | Glu | 5 | 0.2% | 0.0 |
| Cm16 (L) | 2 | Glu | 5 | 0.2% | 0.6 |
| MeLo3a (L) | 3 | ACh | 5 | 0.2% | 0.3 |
| Cm7 (L) | 5 | Glu | 5 | 0.2% | 0.0 |
| MeVP2 (L) | 5 | ACh | 5 | 0.2% | 0.0 |
| TmY5a (L) | 5 | Glu | 5 | 0.2% | 0.0 |
| Tm5Y (L) | 5 | ACh | 5 | 0.2% | 0.0 |
| Tm37 (L) | 5 | Glu | 5 | 0.2% | 0.0 |
| Tm1 (L) | 1 | ACh | 4 | 0.2% | 0.0 |
| Cm34 (L) | 1 | Glu | 4 | 0.2% | 0.0 |
| Cm27 (L) | 3 | Glu | 4 | 0.2% | 0.4 |
| MeTu1 (L) | 3 | ACh | 4 | 0.2% | 0.4 |
| Cm8 (L) | 3 | GABA | 4 | 0.2% | 0.4 |
| Tm5b (L) | 4 | ACh | 4 | 0.2% | 0.0 |
| MeTu3b (L) | 4 | ACh | 4 | 0.2% | 0.0 |
| Cm23 (L) | 1 | Glu | 3 | 0.1% | 0.0 |
| MeVC8 (R) | 1 | ACh | 3 | 0.1% | 0.0 |
| OA-AL2i4 (L) | 1 | OA | 3 | 0.1% | 0.0 |
| MeLo3b (L) | 2 | ACh | 3 | 0.1% | 0.3 |
| TmY9b (L) | 2 | ACh | 3 | 0.1% | 0.3 |
| Dm11 (L) | 2 | Glu | 3 | 0.1% | 0.3 |
| Cm17 (L) | 2 | GABA | 3 | 0.1% | 0.3 |
| Dm9 (L) | 3 | Glu | 3 | 0.1% | 0.0 |
| Cm15 (L) | 3 | GABA | 3 | 0.1% | 0.0 |
| MeTu3c (L) | 3 | ACh | 3 | 0.1% | 0.0 |
| Cm4 (L) | 1 | Glu | 2 | 0.1% | 0.0 |
| Mi9 (L) | 1 | Glu | 2 | 0.1% | 0.0 |
| Cm12 (L) | 1 | GABA | 2 | 0.1% | 0.0 |
| MeLo4 (L) | 1 | ACh | 2 | 0.1% | 0.0 |
| MeVP8 (L) | 1 | ACh | 2 | 0.1% | 0.0 |
| MeVP32 (L) | 1 | ACh | 2 | 0.1% | 0.0 |
| 5-HTPMPV03 (L) | 1 | 5-HT | 2 | 0.1% | 0.0 |
| 5-HTPMPV03 (R) | 1 | 5-HT | 2 | 0.1% | 0.0 |
| Tm12 (L) | 2 | ACh | 2 | 0.1% | 0.0 |
| Tm38 (L) | 2 | ACh | 2 | 0.1% | 0.0 |
| TmY21 (L) | 2 | ACh | 2 | 0.1% | 0.0 |
| Dm8b (L) | 2 | Glu | 2 | 0.1% | 0.0 |
| Cm14 (L) | 2 | GABA | 2 | 0.1% | 0.0 |
| Tm33 (L) | 2 | ACh | 2 | 0.1% | 0.0 |
| Cm24 (L) | 2 | Glu | 2 | 0.1% | 0.0 |
| Cm11c (L) | 2 | ACh | 2 | 0.1% | 0.0 |
| Cm6 (L) | 1 | GABA | 1 | 0.0% | 0.0 |
| TmY10 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| TmY13 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| Cm21 (L) | 1 | GABA | 1 | 0.0% | 0.0 |
| MeTu4f (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| MeVP14 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| Tm39 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| Tm16 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| Mi4 (L) | 1 | GABA | 1 | 0.0% | 0.0 |
| Tm32 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| Tm9 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| Dm12 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| Dm3c (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| MeTu4d (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| MeVP1 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| Dm4 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| Tm26 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| MeVP10 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| Lawf1 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| MeTu4a (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| MeVP9 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| MeVC7a (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| MeVP33 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| MeVP43 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| MeVP41 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| Cm31b (L) | 1 | GABA | 1 | 0.0% | 0.0 |
| downstream partner | # | NT | conns Cm32 | % Out | CV |
|---|---|---|---|---|---|
| Cm1 (L) | 211 | ACh | 796 | 32.1% | 0.6 |
| Cm2 (L) | 103 | ACh | 280 | 11.3% | 0.7 |
| Tm33 (L) | 94 | ACh | 279 | 11.3% | 0.6 |
| Tm12 (L) | 80 | ACh | 182 | 7.4% | 0.6 |
| Cm29 (L) | 3 | GABA | 141 | 5.7% | 0.6 |
| Cm17 (L) | 14 | GABA | 91 | 3.7% | 0.6 |
| Tm5a (L) | 49 | ACh | 75 | 3.0% | 0.7 |
| Dm8b (L) | 39 | Glu | 68 | 2.7% | 0.5 |
| Cm5 (L) | 32 | GABA | 63 | 2.5% | 0.5 |
| Cm26 (L) | 7 | Glu | 55 | 2.2% | 0.7 |
| Tm29 (L) | 27 | Glu | 52 | 2.1% | 0.4 |
| MeVP47 (L) | 1 | ACh | 32 | 1.3% | 0.0 |
| Cm3 (L) | 15 | GABA | 24 | 1.0% | 0.6 |
| MeVP27 (L) | 1 | ACh | 20 | 0.8% | 0.0 |
| Cm19 (L) | 7 | GABA | 14 | 0.6% | 0.7 |
| Tm40 (L) | 9 | ACh | 14 | 0.6% | 0.5 |
| MeVP1 (L) | 10 | ACh | 14 | 0.6% | 0.5 |
| Tm5c (L) | 8 | Glu | 12 | 0.5% | 0.5 |
| Cm4 (L) | 9 | Glu | 12 | 0.5% | 0.4 |
| Tm30 (L) | 9 | GABA | 11 | 0.4% | 0.3 |
| Cm6 (L) | 9 | GABA | 11 | 0.4% | 0.3 |
| Dm2 (L) | 5 | ACh | 10 | 0.4% | 0.5 |
| Tm5b (L) | 8 | ACh | 10 | 0.4% | 0.3 |
| Cm11a (L) | 9 | ACh | 10 | 0.4% | 0.3 |
| Tm32 (L) | 2 | Glu | 9 | 0.4% | 0.1 |
| MeVP52 (L) | 1 | ACh | 8 | 0.3% | 0.0 |
| MeTu3c (L) | 8 | ACh | 8 | 0.3% | 0.0 |
| MeVP21 (L) | 2 | ACh | 7 | 0.3% | 0.7 |
| Pm4 (L) | 5 | GABA | 7 | 0.3% | 0.6 |
| Tm37 (L) | 4 | Glu | 7 | 0.3% | 0.5 |
| Dm-DRA1 (L) | 4 | Glu | 7 | 0.3% | 0.5 |
| MeTu3a (L) | 4 | ACh | 7 | 0.3% | 0.5 |
| Tm6 (L) | 6 | ACh | 7 | 0.3% | 0.3 |
| Cm31b (L) | 1 | GABA | 6 | 0.2% | 0.0 |
| Cm33 (L) | 1 | GABA | 6 | 0.2% | 0.0 |
| TmY10 (L) | 4 | ACh | 6 | 0.2% | 0.3 |
| ME_unclear (L) | 1 | Glu | 5 | 0.2% | 0.0 |
| MeVPMe13 (L) | 1 | ACh | 5 | 0.2% | 0.0 |
| Cm-DRA (L) | 3 | ACh | 5 | 0.2% | 0.6 |
| Cm11d (L) | 3 | ACh | 5 | 0.2% | 0.6 |
| Dm8a (L) | 4 | Glu | 5 | 0.2% | 0.3 |
| Tm20 (L) | 4 | ACh | 5 | 0.2% | 0.3 |
| MeLo4 (L) | 4 | ACh | 5 | 0.2% | 0.3 |
| Cm7 (L) | 3 | Glu | 4 | 0.2% | 0.4 |
| TmY21 (L) | 3 | ACh | 4 | 0.2% | 0.4 |
| MeVP2 (L) | 3 | ACh | 4 | 0.2% | 0.4 |
| Cm11b (L) | 3 | ACh | 4 | 0.2% | 0.4 |
| Tm31 (L) | 4 | GABA | 4 | 0.2% | 0.0 |
| Mi2 (L) | 2 | Glu | 3 | 0.1% | 0.3 |
| MeTu3b (L) | 2 | ACh | 3 | 0.1% | 0.3 |
| MeVP9 (L) | 2 | ACh | 3 | 0.1% | 0.3 |
| MeVC22 (L) | 2 | Glu | 3 | 0.1% | 0.3 |
| Tm39 (L) | 3 | ACh | 3 | 0.1% | 0.0 |
| Mi18 (L) | 3 | GABA | 3 | 0.1% | 0.0 |
| Dm9 (L) | 1 | Glu | 2 | 0.1% | 0.0 |
| Tm4 (L) | 1 | ACh | 2 | 0.1% | 0.0 |
| MeVP8 (L) | 1 | ACh | 2 | 0.1% | 0.0 |
| MeVP41 (L) | 1 | ACh | 2 | 0.1% | 0.0 |
| MeVP29 (L) | 1 | ACh | 2 | 0.1% | 0.0 |
| Cm31a (L) | 1 | GABA | 2 | 0.1% | 0.0 |
| Tm36 (L) | 2 | ACh | 2 | 0.1% | 0.0 |
| Cm8 (L) | 2 | GABA | 2 | 0.1% | 0.0 |
| Cm28 (L) | 2 | Glu | 2 | 0.1% | 0.0 |
| 5thsLNv_LNd6 (L) | 2 | ACh | 2 | 0.1% | 0.0 |
| Mi4 (L) | 1 | GABA | 1 | 0.0% | 0.0 |
| MeVPLo2 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| Tm26 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| MeTu4d (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| Mi16 (L) | 1 | GABA | 1 | 0.0% | 0.0 |
| Tm38 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| MeLo3a (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| MeVP10 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| Cm10 (L) | 1 | GABA | 1 | 0.0% | 0.0 |
| Dm4 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| TmY17 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| Tm5Y (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| aMe26 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| aMe17b (L) | 1 | GABA | 1 | 0.0% | 0.0 |
| MeVPMe4 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| MeVP30 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| aMe12 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| MeVPMe7 (R) | 1 | Glu | 1 | 0.0% | 0.0 |
| MeVP36 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| MeVPMe12 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| DNc02 (R) | 1 | unc | 1 | 0.0% | 0.0 |
| aMe17c (L) | 1 | Glu | 1 | 0.0% | 0.0 |